BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Duke and Duke-NUS Award Over S$1 Million for Climate and Health Research in Landmark Collaboration

The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration Dedicated Research Collaborati...

February 17, 2025 | News

Bambusa Therapeutics Closes $90 Million Series A to Advance Bispecific Antibody Pipeline for Immunological and Inflammatory Disorders

Bambusa Therapeutics, Inc. (Bambusa), a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders, anno...

February 17, 2025 | News

GE HealthCare Invests $138M to Expand Ireland Facility, Boosting Global Contrast Media Supply

New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the en...

February 03, 2025 | News

GHIT Fund Invests JPY 2 Billion (USD 12.7M) in Diagnostics and Drug Development for NTDs and Malaria

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million) in eight projects ...

January 30, 2025 | News

AB2 Bio and Nippon Shinyaku Forge U.S.-Japan Licensing Deal to Launch Tadekinig Alfa for Rare Hyperinflammatory Syndrome

Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic IL...

January 28, 2025 | News

Beckman Coulter and Indiana University School of Medicine Secure $2.5M Grant to Enhance Leukemia and Lymphoma Testing in Western Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been awa...

January 22, 2025 | News

GordonMD and South Korea’s Partners Investment Join Forces to Drive Biopharma Innovation

GordonMD Global Investments® LP (“GordonMD”), a US-based investment manager focused exclusively on global public and private biopharma...

January 22, 2025 | News

R-Bridge Healthcare Fund Provides $40M Financing to Mirxes to Accelerate Global Expansion of Cancer Early Detection Solutions

R-Bridge will provide bespoke financing of US$40 million with a synthetic royalty structure and f...

January 14, 2025 | News

Duke and Duke-NUS Award Over S$1 Million for Climate and Health Research in Landmark Collaboration

Bambusa Therapeutics Closes $90 Million Series A to Advance Bispecific Antibody Pipeline for Immunological and Inflammatory Disorders

GE HealthCare Invests $138M to Expand Ireland Facility, Boosting Global Contrast Media Supply

GHIT Fund Invests JPY 2 Billion (USD 12.7M) in Diagnostics and Drug Development for NTDs and Malaria

AB2 Bio and Nippon Shinyaku Forge U.S.-Japan Licensing Deal to Launch Tadekinig Alfa for Rare Hyperinflammatory Syndrome

Beckman Coulter and Indiana University School of Medicine Secure $2.5M Grant to Enhance Leukemia and Lymphoma Testing in Western Kenya

GordonMD and South Korea’s Partners Investment Join Forces to Drive Biopharma Innovation

R-Bridge Healthcare Fund Provides $40M Financing to Mirxes to Accelerate Global Expansion of Cancer Early Detection Solutions

Aragen Secures $100 Mn Investment from Quadria Capital, Valued at $1.4 Bn

Verismo Therapeutics Secures $4.05M Investment from IFLI to Advance SynKIR™-310 for Follicular Lymphoma

Brii Biosciences Gains Full Control of BRII-179 Intellectual Property in $18M Deal

BeiGene Exercises Exclusive Option for DualityBio's B7H4 ADC, Paving the Way for Global Development

Exicure Signs MOU to Acquire GPCR USA and Advance Collaborative Research in Drug Development

New Therapeutics Venture GEMMABio Secures $34M in Seed Funding to Accelerate Gene Therapy Initiatives

Stay Connected